This inventor holds 2 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2008
Title: Teruki Honma: Innovator in Biarylurea Derivatives
Introduction
Teruki Honma is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can inhibit cancer cell growth. With a total of 2 patents, his work is recognized for its potential impact on cancer treatment.
Latest Patents
Honma's latest patents focus on biarylurea derivatives. The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof. In this formula, Ar is a nitrogen-containing heteroaromatic ring group, X and Z are each a carbon atom, Y is CO, and R is a hydrogen atom. The compounds developed can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, as they exhibit a prominent growth inhibitory activity against tumor cells.
Career Highlights
Honma is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in advancing pharmaceutical research. His innovative approach has led to the development of compounds that hold promise for cancer therapies.
Collaborations
Some of his notable coworkers include Takashi Hayama and Kyoko Hayashi. Their collaborative efforts contribute to the ongoing research and development in the pharmaceutical field.
Conclusion
Teruki Honma's work in biarylurea derivatives showcases his commitment to innovation in cancer treatment. His contributions are paving the way for new therapeutic options in the fight against malignant tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile